Zai Lab (ZLAB) Total Liabilities (2016 - 2026)
Zai Lab (ZLAB) posted Total Liabilities of $433.8 million for Q1 2026, down 5.06% sequentially from $456.9 million in Q4 2025, and up 19.63% YoY from $362.6 million in Q1 2025.
Zai Lab (ZLAB) Total Liabilities (2016 - 2026) Analysis & Trends
Zai Lab has reported Total Liabilities for 11 years, with the latest figure at $433.8 million in Q1 2026.
- Quarterly Total Liabilities rose 19.63% year-over-year to $433.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $433.8 million (up 19.63% YoY) and the FY2025 annual result came in at $456.9 million, up 32.49% from the prior year.
- Total Liabilities declined to $433.8 million in Q1 2026 per ZLAB's latest filing, from $456.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $456.9 million in Q4 2025 and troughed at $162.7 million in Q3 2023.
- A 5-year average of $277.0 million and a median of $240.2 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities fell 24.11% in 2022, then soared 95.24% in 2024.
- Over 5 years, Total Liabilities stood at $174.5 million in 2022, then jumped by 37.6% to $240.2 million in 2023, then jumped by 43.58% to $344.9 million in 2024, then jumped by 32.49% to $456.9 million in 2025, then decreased by 5.06% to $433.8 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $433.8 million, $456.9 million, and $399.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 467.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 467.76 Mn |
| Mar 31, 2026 | 433.76 Mn |
| Dec 31, 2025 | 456.88 Mn |
| Sep 30, 2025 | 399.00 Mn |
| Jun 30, 2025 | 372.37 Mn |
| Mar 31, 2025 | 362.58 Mn |
| Dec 31, 2024 | 344.86 Mn |
| Sep 30, 2024 | 317.68 Mn |
| Jun 30, 2024 | 283.19 Mn |
| Mar 31, 2024 | 226.27 Mn |
| Dec 31, 2023 | 240.18 Mn |
| Sep 30, 2023 | 162.72 Mn |
| Jun 30, 2023 | 174.06 Mn |
| Mar 31, 2023 | 168.83 Mn |
| Dec 31, 2022 | 174.55 Mn |
| Sep 30, 2022 | 192.65 Mn |
| Jun 30, 2022 | 206.61 Mn |
| Mar 31, 2022 | 192.91 Mn |
| Dec 31, 2021 | 230.00 Mn |
| Sep 30, 2021 | 140.15 Mn |